Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Larsucosterol sodium by DURECT for Alcoholic Hepatitis: Likelihood of Approval
Larsucosterol sodium is under clinical development by DURECT and currently in Phase II for Alcoholic Hepatitis. According to GlobalData, Phase...